ライフサイエンスコーパス: choroidal

1 ge, 1.46-7.90 mm2] in group 3; P = .001) and choroidal (11.83 [5.55] mm2 [range, 4.55-22.14 mm2] in g

2 ptic nerve invasion, or combined non-massive choroidal and prelaminar/laminar optic nerve invasion.

3 ilateral optic disc edema, globe flattening, choroidal and retinal folds, hyperopic refractive error

4 To evaluate choroidal and suprachoroidal changes following suprachor

5 Models of retinal and choroidal angiogenesis, including oxygen-induced retinop

6 ed fatty acids (LC-PUFAs) reduce retinal and choroidal angiogenesis.

7 etermined by dividing vascular area by total choroidal area.

8 older affected members showed severe central choroidal atrophy.

9 o appear in highly myopic eyes with advanced choroidal atrophy.

10 iography revealed gradual restoration of the choroidal blood flow and unmasking of the big choroidal

11 migraine patients without aura and pulsative choroidal blood flow may not be affected during the chro

12 In this model, glucose from the choroidal blood passes through the retinal pigment epith

13 Abnormal growth of choroidal blood vessels, or choroidal neovascularization

14 entries, 3217 patients with ciliary body and choroidal (CBC) melanoma and 160 with iris melanoma were

15 revalence of drusen-like deposits (DLDs) and choroidal changes in patients with systemic lupus erythe

16 The aim of this study was to evaluate choroidal changes occurring in asymptomatic, acute and c

17 ficant effect in alive rabbit eyes; however, choroidal circulation seems to be a significant effect t

18 sive method of 3D imaging of the retinal and choroidal circulations.

19 nd CH with craniofacial dysmorphic features, choroidal coloboma and endoderm-derived organ malformati

20 (RPE)/choroid and positively correlated with choroidal degeneration in the early stages of retinopath

21 (n = 1; 2.3%), wound leak (n = 1; 2.3%), and choroidal detachment (n = 2; 4.5%).

22 endophthalmitis in 6.3% (3 of 48 eyes), and choroidal detachment or hemorrhage in 8.3% (4 of 48 eyes

23 (all but 2 spontaneously resolving) included choroidal effusion (1), vitreous hemorrhage (3), Desceme

24 P increase (n = 9), pupillary block (n = 1), choroidal effusion (n = 2), CME (n = 4), and redislocati

25 branch retinal artery occlusion and multiple choroidal emboli.

26 family members are expressed in retinal and choroidal endothelial cells (ECs).

27 Human choroidal endothelial cells expressed lower TRPV4 mRNA/p

28 xamined by 2 experts to document retinal and choroidal findings.

29 cation of the regional structural context of choroidal flow interest between different imaging modali

30 For each patient, these areas of choroidal flow void on OCTA persisted during the follow-

31 All eyes had inner choroidal flow void on OCTA that topographically corresp

32 apillary wrinkles (PPW), retinal folds (RF), choroidal folds (CF), and creases using transaxial and e

33 uts experience ophthalmic changes, including choroidal folds, optic disc edema, cotton-wool spots, gl

34 tudy were to further define the functions of choroidal gammadelta T cells and to explore the underlyi

35 Our data demonstrate that choroidal gammadelta T cells are activated by RPE injury

36 We have previously reported the presence of choroidal gammadelta T cells in a model of chronic degen

37 Choroidal gammadelta T cells in protection against retin

38 ns revealed altered outer retinal layers and choroidal hypertransmission.

39 trols with emmetropia in both eyes underwent choroidal imaging using spectral-domain optical coherenc

40 ome contributed to both the acute unilateral choroidal infarction and to the chronic development of b

41 This revealed an antecedent choroidal infarction that explained the visual field sco

42 erm follow-up of a young female patient with choroidal infarction, primary open angle glaucoma and Fl

43 8 eyes (51%), with characteristic multifocal choroidal infiltrates in 29 eyes (39%).

44 en on multimodal imaging include histiocytic choroidal infiltration causing choroidal lesions, compli

45 e presence of a thin choroid, a perivascular choroidal inflammatory infiltrate, and atrophic changes

46 For the detection of co-occurring massive choroidal invasion and postlaminar optic nerve invasion

47 body/muscle infiltration, massive (>/=3 mm) choroidal invasion, retrolaminar optic nerve invasion, o

48 e investigated the mechanisms underlying the choroidal involution and its long-term impact on retinal

49 We have recently demonstrated that choroidal involution occurs early in retinopathy.

50 retinal vasculitis (374 of 874 [42.8%]), and choroidal involvement (419 of 651 [64.4%]).

51 patients with panuveitis having vitreous and choroidal involvement had a higher risk of treatment fai

52 5% CI, 1.18-11.62; P = .02), and presence of choroidal involvement had an adjusted HR of 2.88 (95% CI

53 were obtained at the outer retinal layer and choroidal layer levels.

54 ment with sorafenib showed regression of the choroidal lesions and resolution of the SRD on multimoda

55 Patients with few choroidal lesions had a favorable outcome, whereas all p

56 cent on ICG angiography, and correlated with choroidal lesions on SD OCT.

57 The extent of choroidal lesions varied from few in 2 patients to wides

58 Choroidal lesions were identified and analyzed in four o

59 Multifocal choroidal lesions were observed bilaterally in all patie

60 e histiocytic choroidal infiltration causing choroidal lesions, complicated by recurrent serous retin

61 is, optic disc swelling, and white-yellowish choroidal lesions.

62 at the outer retinal layer level than at the choroidal level in group 3 (47.70% [31.30%] [range, 13.6

63 laris starting at a size much smaller than a choroidal lobule.

64 Retinal microglia, choroidal macrophages, and recruited monocytes, collecti

65 atients treated with proton beam therapy for choroidal melanoma (CM), using optical coherence tomogra

66 d effective tumor control for juxtapapillary choroidal melanoma and may be associated with reduced ra

67 3DUS in 45 consecutive patients with primary choroidal melanoma to determine the percentage agreement

68 All patients with primary ciliary body or choroidal melanoma treated with iodine 125 or ruthenium

69 s of 57 patients with a clinically diagnosed choroidal melanoma underwent complete 25-gauge posterior

70 f radiation to the fovea, many patients with choroidal melanoma with foveal involvement maintain usef

71 Forty-seven patients with juxtapapillary choroidal melanoma.

72 dose plaque brachytherapy for juxtapapillary choroidal melanoma.

73 optimal therapeutic dose for juxtapapillary choroidal melanoma.

74 nsecutive cohort study of patients with T3-4 choroidal melanomas according to the 7th edition of the

75 cy of proton beam irradiation (PBI) of large choroidal melanomas has not been reported.

76 Three hundred fifty-one patients with choroidal melanomas located 1 disc diameter (DD) or less

77 s of 57 patients with treatment-naive medium choroidal melanomas without extraocular extension from J

78 owth following globe-preserving treatment of choroidal melanomas, and may be a valuable prognostic in

79 of 203 of the patients with small and medium choroidal melanomas, the effect of a reduced dose of rad

80 who underwent PBI for the treatment of large choroidal melanomas.

81 ive therapeutic option for the management of choroidal metastasis in selected cases.

82 technique that can visualize the retinal and choroidal microvasculature without the injection of exog

83 es were matched at baseline for VA, age, and choroidal neovascular membrane (CNV) size.

84 ) looking at risk factors for development of choroidal neovascular membrane (CNVM) and visual loss.

85 For analyses by visit: choroidal neovascular membrane activity graded by the tr

86 because this cohort of patients had advanced choroidal neovascular membrane upon enrollment (recurren

87 To describe the characteristics of pediatric choroidal neovascular membranes (CNVs) associated with r

88 in photodynamic therapy for the treatment of choroidal neovascular membranes, has also been shown to

89 ow to monitor for the early detection of the choroidal neovascular stage before substantial vision lo

90 treal SH-11037 (1 muM) significantly reduced choroidal neovascularisation (CNV) lesion volume in the

91 ct Cynomolgus against laser-induced grade IV choroidal neovascularisation (CNV).

92 In a mouse model with choroidal neovascularisation akin to age-related macular

93 ment epithelium (RPE) deposits, RPE atrophy, choroidal neovascularisation and photoreceptor cell deat

94 ociations between all rare pLoF variants and choroidal neovascularization (CNV) (OR, 1.34; 95% CI, 1.

95 lemonitoring for early detection of incident choroidal neovascularization (CNV) among patients with a

96 Choroidal neovascularization (CNV) and capillary dilatio

97 cholesterolemia, worse visual acuity, larger choroidal neovascularization (CNV) area, retinal angioma

98 wever, these mice develop significantly less choroidal neovascularization (CNV) compared to wild-type

99 ace changes over time and their influence on choroidal neovascularization (CNV) development.

100 raphy angiography (OCTA) in the detection of choroidal neovascularization (CNV) in age-related macula

101 acteristics and natural history of quiescent choroidal neovascularization (CNV) in geographic atrophy

102 was an 85.5% mean reduction from baseline in choroidal neovascularization (CNV) size.

103 In contrast to the choroidal neovascularization (CNV) subtype, the genetic

104 was more prominent in patients with classic choroidal neovascularization (CNV) than those with occul

105 Choroidal neovascularization (CNV) was manually segmente

106 The molecular pathogenesis of choroidal neovascularization (CNV), an angiogenic proces

107 data from retinas treated with laser-induced choroidal neovascularization (CNV), bright white-light e

108 normal growth of choroidal blood vessels, or choroidal neovascularization (CNV), is a hallmark of the

109 -induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV), mimicking hypoxia-me

110 ous proliferation (RAP) lesions, and classic choroidal neovascularization (CNV).

111 ent white dot syndrome (MEWDS) who developed choroidal neovascularization (CNV).

112 of irreversible blindness and manifests with choroidal neovascularization (CNV).

113 cular degeneration (AMD) is characterized by choroidal neovascularization (CNV).

114 te AMD subtypes; geographic atrophy (GA) and choroidal neovascularization (CNV).

115 outcomes in eyes with treatment-naive myopic choroidal neovascularization (mCNV) in the United States

116 l fibrosis after regression of laser-induced choroidal neovascularization and a decrease in mesenchym

117 These retinal lesions can be associated with choroidal neovascularization and central serous choriore

118 6.0 diopters with the presence of subretinal/choroidal neovascularization as indicated by Internation

119 al neovascularization in 3 eyes and inactive choroidal neovascularization in 1 eye.

120 f a hyperflow signal corresponding to active choroidal neovascularization in 3 eyes and inactive chor

121 pressed initiation and growth of spontaneous choroidal neovascularization in a mouse model, and the c

122 aditional multimodal imaging, helps diagnose choroidal neovascularization in patients with Malattia L

123 efined as HM with the presence of subretinal/choroidal neovascularization indicated by the ICD-9-CM d

124 Pigmented mice with laser-induced choroidal neovascularization lesions (n = 7 eyes) were a

125 ffect on both area and number of spontaneous choroidal neovascularization lesions.

126 r of patients with treatment-naive subfoveal choroidal neovascularization receiving intravitreal rani

127 participants, aged >/=50 years, with active choroidal neovascularization secondary to AMD.

128 The mother had choroidal neovascularization that was treated with bevac

129 Current treatments for choroidal neovascularization, a major cause of blindness

130 inal pigment epithelium (RPE) abnormalities, choroidal neovascularization, acquired vitelliform lesio

131 ng oxygen-induced retinopathy, laser-induced choroidal neovascularization, and transgenic mouse model

132 models with deficient or spontaneous retinal/choroidal neovascularization, as well as models with ind

133 se vision than their mother, despite lacking choroidal neovascularization, because of the extent of p

134 ctional role for TLR2 in the pathogenesis of choroidal neovascularization, likely by promoting inflam

135 escein-negative intraretinal cystic changes, choroidal neovascularization, serous retinal elevations

136 n 2 (12%), a dome-shaped macula in 1 (6%), a choroidal neovascularization-related subretinal scar in

137 tion of nitric oxide (NO) in macrophages and choroidal neovascularization.

138 2 as a novel therapeutic target for reducing choroidal neovascularization.

139 nd photoreceptors and can be associated with choroidal neovascularization.

140 fundus changes and potentially of subsequent choroidal neovascularization.

141 n strongly implicated in the pathogenesis of choroidal neovascularization.

142 s, both normal and with macular degeneration/choroidal neovascularization.

143 features from pathologic RPE detachments and choroidal neovascularizations (CNVs).

144 ield imaging increased the identification of choroidal nevi by 27% (406 eyes [5.3%] by NMFP vs 545 ey

145 n: Three patients with a recent diagnosis of choroidal nevi underwent a novel adaptive optical assess

146 ld change the current clinical evaluation of choroidal nevi.

147 es in the photoreceptor mosaic overlying the choroidal nevi.

148 or abnormalities in the retina overlying the choroidal nevi.

149 treated with primary proton beam therapy for choroidal or ciliary body melanoma between June 1998 and

150 Severity of acute ischemic damage to the choroidal, outer retinal and optic nerve head.

151 Age and axial length were associated with choroidal parameters in healthy subjects.

152 Novel choroidal parameters such as choroidal reflectivity may

153 , was computed using the formula: normalized choroidal reflectivity = (choroidal reflectivity-vitreou

154 There was a negative correlation between choroidal reflectivity and choroidal thickness (r = -0.7

155 Choroidal reflectivity and choroidal thickness changes a

156 Choroidal reflectivity and choroidal thickness.

157 Higher choroidal reflectivity and lower choroidal thickness wer

158 To characterize choroidal thickness and choroidal reflectivity in the eyes of patients with bird

159 Novel choroidal parameters such as choroidal reflectivity may warrant further study in the

160 An adjusted or normalized choroidal reflectivity, with the RPE as the bright refer

161 ormula: normalized choroidal reflectivity = (choroidal reflectivity-vitreous reflectivity)/RPE reflec

162 P < 0.01) all were significant predictors of choroidal reflectivity.

163 ak, endophthalmitis, intravitreal injection, choroidal retinal vitreal biopsy, and human immunodefici

164 3) and VCT (0.750-0.869), even in eyes where choroidal-scleral junction visibility was <75%.

165 EDI-OCT images were obtained and the choroidal-scleral junction was analyzed through semiauto

166 ak and Arden ratio (P = .06) and presence of choroidal spots on infracyanine green angiograms (80.0%

167 2) mum below the RPE reference plane and the choroidal stalks at 80.4 (24.4) mum below RPE reference

168 e within the dome of the RPE detachment, the choroidal stalks were all in the choroid layer.

169 y lesions in 3 patients leading to localized choroidal thickening with elevation of the overlying ret

170 e LD-BM was influenced significantly more by choroidal thickness (1.14 mum/mum; 95% confidence interv

171 To identify changes in choroidal thickness (CT) and all retinal layers of diabe

172 The aim of this study was to evaluate the choroidal thickness (CT) changes in obese women, using o

173 To provide a normal database of choroidal thickness (CT) in nine Early Treatment Diabete

174 SS OCT was used to obtain automatic macular choroidal thickness (CT) maps, according to the Early Tr

175 central macula affect the reproducibility of choroidal thickness (CT) measurements on enhanced depth

176 ral retinal thickness (CRT [excluding SND]); choroidal thickness (CT); nasal and temporal retinal thi

177 Foveal choroidal thickness (FCT), subretinal hyperreflective ma

178 A higher baseline choroidal thickness (for every 100-mum increase in choro

179 tiplying the average CVD by macular area and choroidal thickness (obtained with SS-OCT automated soft

180 omatically segment and measure peripapillary choroidal thickness (PCT) from circle scans centered on

181 We found that thinner peripapillary choroidal thickness (PPCT) was independently associated

182 rrelation between choroidal reflectivity and choroidal thickness (r = -0.793; P < 0.001).

183 Subfoveal choroidal thickness (SCT) was measured using the SDOCT.

184 measures of rod-mediated dark adaptation and choroidal thickness (time to rod intercept versus choroi

185 idal thickness (time to rod intercept versus choroidal thickness 0.072 (CI95 -0.23 to 0.38) min/100 m

186 Choroidal thickness 2.5 degrees above the fovea was 348

187 scores and age, RIT, AMD severity, subfoveal choroidal thickness [SFCT], phakic status, and best-corr

188 ly significant except for the association of choroidal thickness and "peripheral vision." The stronge

189 A negative correlation between subfoveal choroidal thickness and age was detected in all regions

190 ver, because the genetic correlation between choroidal thickness and AMD severity was not significant

191 Phenotypic correlation between choroidal thickness and CARMS category was moderate (Spe

192 To characterize choroidal thickness and choroidal reflectivity in the ey

193 Repeatability and heritability of choroidal thickness and its phenotypic and genetic corre

194 In subjects with intermediate AMD, choroidal thickness and vessel volume are reduced in the

195 correlate interobserver findings and compare choroidal thickness and visual acuity at each time point

196 ctional measurements of DA testing (RIT) and choroidal thickness are associated with patient-reported

197 hy, central retinal thickness, and subfoveal choroidal thickness are likely to be valuable in monitor

198 For data analysis, we considered mean choroidal thickness as the arithmetic mean value of the

199 The choroidal thickness at the foveal center was measured.

200 There was no statistical difference in the choroidal thickness between the different time points (b

201 Choroidal reflectivity and choroidal thickness changes are evident in active and in

202 Choroidal thickness changes were similar despite differe

203 a reference plane to reduce the influence of choroidal thickness changes.

204 Active BSCR patients showed lower choroidal thickness compared with controls (P < 0.01).

205 Choroidal thickness decreased 6 months after surgery (P

206 Subfoveal choroidal thickness decreased significantly in both typi

207 Subfoveal choroidal thickness decreased with age, whereas central

208 al thickness when trying to estimate overall choroidal thickness from any central measurement.

209 choroidal injection of CLS-TA does not alter choroidal thickness in eyes with macular edema due to RV

210 The increase in choroidal thickness is a feature of the LHON acute stage

211 Macular choroidal thickness measured to the outer choroidal vess

212 e interobserver correlation was obtained for choroidal thickness measurements (r = 0.97, P < 0.0001)

213 Choroidal thickness measurements are more reproducible w

214 Choroidal thickness therefore may capture variation not

215 oveal fluid and a reduction of the subfoveal choroidal thickness to 271 mum after a 3 months follow-u

216 e test for genetic variation associated with choroidal thickness to determine the overlap in genetic

217 macular subretinal fluid with an increase of choroidal thickness up to 341 mum.

218 Mean subfoveal choroidal thickness was 156 mum (147, 42-362 mum) for GA

219 Reduction in choroidal thickness was associated with elevated C-react

220 Subfoveal choroidal thickness was greater in patients with SLE (P

221 Choroidal thickness was highly repeatable within individ

222 Choroidal thickness was measured at each time point (bas

223 Baseline subfoveal choroidal thickness was not significantly different betw

224 Higher choroidal reflectivity and lower choroidal thickness were documented in inactive BSCR pat

225 ayer thickness, in addition to peripapillary choroidal thickness were measured.

226 There is a consistent overestimation of choroidal thickness when trying to estimate overall chor

227 DRI SS OCT provides a topographic map of choroidal thickness with an ETDRS layout.

228 Baseline predictors (particularly choroidal thickness) for functional response (best-corre

229 dal thickness (for every 100-mum increase in choroidal thickness) was found to be a positive predicto

230 On multiple regression analysis, choroidal thickness, age, and disease duration (all P <

231 ar coherence tomography was used to quantify choroidal thickness, and fundus photography was used to

232 jects, to evaluate macular and peripapillary choroidal thickness, and retinal nerve fiber layer (RNFL

233 CR also worsened with increasing choroidal thickness, but was not affected by retinal thi

234 ce of thickest point from the foveal center, choroidal thickness, choroidal volume, choroidal vascula

235 wide range of individual rates of change of choroidal thickness, from -20.00 to 17.09 mum/year (mean

236 on the LLQ, with both reduced DA and reduced choroidal thickness, in a population of older adults wit

237 levations mimicking retinal folds, increased choroidal thickness, lack of rapid visual recovery, and

238 Choroidal thickness, refraction and ocular axial length

239 urements of RNFL thickness and peripapillary choroidal thickness, respectively.

240 ickness, VCT), outer choroid stroma (stromal choroidal thickness, SCT), or inner scleral border (tota

241 ckness, SCT), or inner scleral border (total choroidal thickness, TCT) showed no significant changes

242 o the outer choroidal vessel lumen (vascular choroidal thickness, VCT), outer choroid stroma (stromal

243 d PEDs associated with polyps and a variable choroidal thickness, while CSC patients had a thick chor

244 nalyses, RIT had a stronger association than choroidal thickness.

245 longed DA testing (longer RIT) and decreased choroidal thickness.

246 ly in eyes with subretinal fluid and greater choroidal thickness.

247 daptation can be attributed to variations in choroidal thickness.

248 ti-VEGF injections, PDT therapy, or baseline choroidal thickness.

249 with enhanced depth imaging mode to measure choroidal thickness.

250 focal dark adaptation (DA) testing and with choroidal thickness.

251 eme lighting," and "mobility" also including choroidal thickness.

252 Choroidal reflectivity and choroidal thickness.

253 I SS OCT, and line measurements of subfoveal choroidal thicknesses (SFCT) were also performed.

254 es (100%), retinal thinning in 8 eyes (89%), choroidal thinning in 7 eyes (78%), and colobomatouslike

255 Our study suggests that choroidal thinning in eyes with high myopia is associate

256 To evaluate the rate of peripapillary choroidal thinning in glaucoma patients and healthy cont

257 Significant choroidal thinning occurred in most patients (25/28 [89%

258 The rate of peripapillary choroidal thinning was not significantly different betwe

259 thinning of the retinal pigment epithelium, choroidal thinning, undifferentiated nuclear layers of t

260 ocalizing with severe RPE depigmentation and choroidal thinning.

261 Choroidal tuberculosis is present in 5-20% of patients w

262 (95% CI: 0.59, 0.80; P = .0004) for massive choroidal tumor invasion (n = 219).

263 All relapsing patients had choroidal tumors and 15 presented with visual symptoms.

264 s with high myopia, after adjusting for age, choroidal vascular and stromal areas were significantly

265 nter, choroidal thickness, choroidal volume, choroidal vascular and stromal areas within the macular

266 l imaging findings in AMN, with attention to choroidal vascular changes.

267 To compare choroidal vascular density (CVD) and volume (CVV) in dia

268 Choroidal vascular density (CVD) was calculated as a per

269 Choroidal vascular density and volume are significantly

270 To compare choroidal vascular features of eyes with and without sub

271 These findings suggest that areas of inner choroidal vascular flow void on OCTA are seen in patient

272 Compared to control eyes with emmetropia, choroidal vascularity was greater in eyes with high myop

273 ular (6 mm) and foveal (1.5 mm) regions, and choroidal vascularity, which was determined by dividing

274 SS OCT en face images of choroidal vasculature were also captured and converted t

275 En face SS-OCT images of the choroidal vasculature were binarized.

276 ess in vivo visualization of the retinal and choroidal vasculature.

277 re observed in 7 cases, including polypoidal choroidal vasculopathy (PCV) and macular fibrosis or atr

278 and volume predict retreatment in polypoidal choroidal vasculopathy (PCV).

279 erstanding of the pathogenesis of polypoidal choroidal vasculopathy (PCV).

280 Historically, polypoidal choroidal vasculopathy complexes are less responsive to

281 l of intravitreal aflibercept for polypoidal choroidal vasculopathy in 21 eyes was conducted.

282 Eyes with polypoidal choroidal vasculopathy previously treated with ranibizum

283 ions with regression of polyps in polypoidal choroidal vasculopathy.

284 ting aflibercept in management of polypoidal choroidal vasculopathy.

285 further exploration of the contributions of choroidal vessel disease to diabetic eye disease pathoge

286 The presence of a large choroidal vessel elevating the RPE and the absence of ab

287 ar choroidal thickness measured to the outer choroidal vessel lumen (vascular choroidal thickness, VC

288 pro-angiogenic proteins that promote ex vivo choroidal vessel sprouting.

289 Mean choroidal vessel volume was also significantly reduced i

290 Choroidal vessel volume was calculated by multiplying th

291 ted from the presence of an underlying large choroidal vessel.

292 demonstrated hyperreflectivity around large choroidal vessels and at the level of the choriocapillar

293 , depigmented fundus, unmasking of the large choroidal vessels and optic atrophy; fluorescein angiogr

294 was calculated as a percent area occupied by choroidal vessels in a 6-mm-diameter submacular circular

295 , calculated as the percent area occupied by choroidal vessels in the central macular region (6-mm-di

296 In all eyes, RPE humps corresponded to large choroidal vessels lifting the RPE.

297 The dense autonomic innervation of the choroidal vessels predisposes them particularly to vasos

298 horoidal blood flow and unmasking of the big choroidal vessels.

299 ells in subretinal space, and a reduction of choroidal vessels.

300 from the foveal center, choroidal thickness, choroidal volume, choroidal vascular and stromal areas w